Funded equally by LUNGevity Foundation and the American Lung Association
Michael Tainsky, PhD
Wayne State University, Karmanos Cancer Institute
Detroit
Dr. Tainsky has developed a technology that takes advantage of the responses of the human immune system to identify cancer-associated proteins that bind to antibodies present in the blood of cancer patients but not in the blood of healthy subjects or those with benign diseases. Dr. Tainsky is working to develop a non-invasive screening test for the early detection of lung cancer by using cancer-associated antigens as biomarkers.